Home Newsfeeds Raymond James Maintains Strong Buy on UserTesting, Lowers Price Target to $9

Raymond James Maintains Strong Buy on UserTesting, Lowers Price Target to $9

Raymond James analyst Brian Peterson maintains UserTesting (NYSE:USER) with a Strong Buy and lowers the price target from $14 to $9.

byBenzinga Newsdesk

August 5, 2022

1 minute read

Raymond James analyst Brian Peterson maintains UserTesting (NYSE:USER) with a Strong Buy and lowers the price target from $14 to $9.

Oracle Likely To Report Lower Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts

By Avi Kapoor

June 10, 11:27 AM

Oracle Corporation (NYSE:ORCL) will release earnings results for its fourth quarter, after the closing bell on Tuesday. Analysts…

ORCL

Donaldson, Hewlett Packard Enterprise And 3 Stocks To Watch Heading Into Tuesday

By Avi Kapoor

June 4, 3:23 AM

With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor…

BARK

Transcat Views Becnel As A Great Addition To Its Rental Portfolio With Expected Margin Boost: Details

By Shivani Kumaresan

April 15, 12:03 PM

Explore Transcat Inc's latest acquisition of Becnel Rental Tools LLC, marking a strategic move in the oil and gas industry. With a $50 million investment, including $32.5 million in stock, Transcat expands its portfolio to include Becnel's ISO 9001:2015 certified rental tools and services.

TRNS

Results Of Three Investigator-Initiated Trials On Cadonilimab For G/GEJC, pMMR/MSS mCRC, And HCC Neoadjuvant Therapy Published At ESMO Asia 2023

By Benzinga Newsdesk

December 5, 9:16 AM

First-line therapy for gastric cancer and metastatic colorectal cancer, neoadjuvant therapy for hepatocellular carcinomaHONGKONG, Dec. 5, 2023 /PRNewswire/ -- Akeso (9926.HK) published results from three

LNVGY

Raymond James Maintains Strong Buy on UserTesting, Lowers Price Target to $9

Related Posts

Oracle Likely To Report Lower Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts

Donaldson, Hewlett Packard Enterprise And 3 Stocks To Watch Heading Into Tuesday

Transcat Views Becnel As A Great Addition To Its Rental Portfolio With Expected Margin Boost: Details

Results Of Three Investigator-Initiated Trials On Cadonilimab For G/GEJC, pMMR/MSS mCRC, And HCC Neoadjuvant Therapy Published At ESMO Asia 2023